Annual Cash & Cash Equivalents
$98.68 M
+$78.36 M+385.55%
December 31, 2023
Summary
- As of February 7, 2025, IMNM annual cash & cash equivalents is $98.68 million, with the most recent change of +$78.36 million (+385.55%) on December 31, 2023.
- During the last 3 years, IMNM annual cash & cash equivalents has risen by +$58.91 million (+148.15%).
- IMNM annual cash & cash equivalents is now at all-time high.
Performance
IMNM Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$155.57 M
-$9.76 M-5.91%
September 30, 2024
Summary
- As of February 7, 2025, IMNM quarterly cash and cash equivalents is $155.57 million, with the most recent change of -$9.76 million (-5.91%) on September 30, 2024.
- Over the past year, IMNM quarterly cash and cash equivalents has increased by +$56.89 million (+57.65%).
- IMNM quarterly cash and cash equivalents is now -42.32% below its all-time high of $269.72 million, reached on March 31, 2024.
Performance
IMNM Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
IMNM Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +385.6% | +57.6% |
| 3 y3 years | +148.2% | +665.5% |
| 5 y5 years | +6059.7% | +665.5% |
IMNM Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +385.6% | -42.3% | +665.5% |
| 5 y | 5-year | at high | +3780.4% | -42.3% | +6017.5% |
| alltime | all time | at high | +6059.7% | -42.3% | +6017.5% |
Immunome Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $155.57 M(-5.9%) |
| Jun 2024 | - | $165.33 M(-38.7%) |
| Mar 2024 | - | $269.72 M(+173.3%) |
| Dec 2023 | $98.68 M(+385.6%) | $98.68 M(+8.9%) |
| Sep 2023 | - | $90.64 M(+135.9%) |
| Jun 2023 | - | $38.42 M(-13.5%) |
| Mar 2023 | - | $44.42 M(+118.6%) |
| Dec 2022 | $20.32 M | $20.32 M(-24.9%) |
| Sep 2022 | - | $27.08 M(-21.9%) |
| Jun 2022 | - | $34.65 M(-19.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $42.88 M(-12.9%) |
| Dec 2021 | $49.23 M(+23.8%) | $49.23 M(-12.5%) |
| Sep 2021 | - | $56.24 M(-6.0%) |
| Jun 2021 | - | $59.83 M(+64.9%) |
| Mar 2021 | - | $36.28 M(-8.8%) |
| Dec 2020 | $39.77 M(+1463.7%) | $39.77 M(+489.7%) |
| Sep 2020 | - | $6.74 M(-31.1%) |
| Jun 2020 | - | $9.79 M(+284.9%) |
| Dec 2019 | $2.54 M(+58.7%) | $2.54 M |
| Dec 2018 | $1.60 M | - |
FAQ
- What is Immunome annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Immunome?
- What is Immunome annual cash & cash equivalents year-on-year change?
- What is Immunome quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Immunome?
- What is Immunome quarterly cash and cash equivalents year-on-year change?
What is Immunome annual cash & cash equivalents?
The current annual cash & cash equivalents of IMNM is $98.68 M
What is the all time high annual cash & cash equivalents for Immunome?
Immunome all-time high annual cash & cash equivalents is $98.68 M
What is Immunome annual cash & cash equivalents year-on-year change?
Over the past year, IMNM annual cash & cash equivalents has changed by +$78.36 M (+385.55%)
What is Immunome quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of IMNM is $155.57 M
What is the all time high quarterly cash and cash equivalents for Immunome?
Immunome all-time high quarterly cash and cash equivalents is $269.72 M
What is Immunome quarterly cash and cash equivalents year-on-year change?
Over the past year, IMNM quarterly cash and cash equivalents has changed by +$56.89 M (+57.65%)